ONCOQUEST Trademark

Trademark Overview

On Monday, January 20, 2020, a trademark application was filed for ONCOQUEST with the United States Patent and Trademark Office. The USPTO has given the ONCOQUEST trademark a serial number of 88765723. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, April 7, 2023. This trademark is owned by ONCOQUEST INC.. The ONCOQUEST trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate, all for human clinical and medical use, namely, immunoglobulins; Biologics from animal blood, animal blood plasma, fractionated animal blood plasma, all for human clinical and medical use, namely, immunoglobulins; Pharmaceutical preparations for the prevention and treatment of cancer

Scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Research and development of new products, drugs and technology in the field of cancer
oncoquest

General Information

Serial Number88765723
Word MarkONCOQUEST
Filing DateMonday, January 20, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, April 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate, all for human clinical and medical use, namely, immunoglobulins; Biologics from animal blood, animal blood plasma, fractionated animal blood plasma, all for human clinical and medical use, namely, immunoglobulins; Pharmaceutical preparations for the prevention and treatment of cancer
Pseudo MarkONCOLOGY QUEST
Goods and ServicesScientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Research and development of new products, drugs and technology in the field of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 24, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameONCOQUEST INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdmonton, AB T6E6S4
CA

Trademark Events

Event DateEvent Description
Friday, April 7, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, April 7, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, April 7, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 21, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, December 21, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, December 21, 2022SUSPENSION INQUIRY WRITTEN
Friday, June 3, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 3, 2022LETTER OF SUSPENSION E-MAILED
Friday, June 3, 2022SUSPENSION LETTER WRITTEN
Thursday, May 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 24, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 1, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, December 1, 2021INQUIRY TO SUSPENSION E-MAILED
Wednesday, December 1, 2021SUSPENSION INQUIRY WRITTEN
Thursday, November 18, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, May 17, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 17, 2021LETTER OF SUSPENSION E-MAILED
Monday, May 17, 2021SUSPENSION LETTER WRITTEN
Monday, May 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 10, 2021ASSIGNED TO LIE
Tuesday, May 4, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, December 8, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, December 8, 2020INQUIRY TO SUSPENSION E-MAILED
Tuesday, December 8, 2020SUSPENSION INQUIRY WRITTEN
Thursday, November 19, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, November 19, 2020ASSIGNED TO LIE
Friday, April 10, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 10, 2020LETTER OF SUSPENSION E-MAILED
Friday, April 10, 2020SUSPENSION LETTER WRITTEN
Friday, April 10, 2020EXAMINER'S AMENDMENT ENTERED
Friday, April 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 10, 2020EXAMINERS AMENDMENT E-MAILED
Friday, April 10, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 8, 2020ASSIGNED TO EXAMINER
Friday, January 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 23, 2020NEW APPLICATION ENTERED

Related Keywords

oncoquest blood human plasma biologics animal immunoglobulins cancer medical research namely